Chantix and Zyban Labels Get New Warnings
On July 1, 2009, the FDA announced that the agency will require two smoking-cessation drugs, Chantix and Zyban, to carry the agency's strongest safety warning over side effects including depression and suicidal thoughts. The new requirement is based on reports of people experiencing unusual changes in behavior, becoming depressed, or ...